Table 1.
Parameter | Total cohort n=1313 | Participants with DNA-M data at age 18 n=370 | p-value |
---|---|---|---|
|
|||
Median (5%, 95% value); n | |||
Height | |||
Boys | 178 (167, 190); 483 | 177.3 (167, 187.3); 124 | 0.3 |
Girls | 164 (154.5, 175); 511 | 165 (154, 176); 243 | 0.44 |
Weight | |||
Boys | 69 (55.6, 91.2); 468 | 70 (56, 97.2); 123 | 0.38 |
Girls | 61.14 (48.5, 90.1); 502 | 61.45 (50.4, 89.1); 240 | 0.63 |
BMI | |||
Boys | 21.7 (18.1, 30.0); 465 | 21.85 (18.3, 29.1); 123 | 0.38 |
Girls | 22.86 (18.2, 13.7); 499 | 22.88 (19.1, 32.9); 240 | 0.57 |
FVC | |||
Boys | 5.34 (4.21, 6.60); 395 | 5.34 (4.11, 6.70); 119 | 0.99 |
Girls | 3.98 (3.1, 4.8); 443 | 4.05 (3.19, 5.02); 237 | 0.07 |
FEV1 | |||
Boys | 4.55 (3.64, 5.63); 396 | 4.57 (3.59, 5.62); 119 | 0.59 |
Girls | 3.48 (2.72,4.17); 443 | 3.54 (2.81, 4.26); 237 | 0.08 |
FEV1/FVC | |||
Boys | 0.87 (0.74, 0.98); 396 | 0.87 (0.77, 0.99); 119 | 0.6 |
Girls | 0.88 (0.75, 0.98); 443 | 0.88 (0.75, 0.98); 237 | 0.66 |
FEF25-75% | |||
Boys | 4.97 (3.23, 6.84); 396 | 5.12 (3.42, 6.94); 119 | 0.42 |
Girls | 4.00 (2.5, 5.4); 443 | 4.05 (2.55, 5.42); 237 | 0.33 |
ENO | |||
Boys | 19.0 (7, 108); 387 | 18.00 (7, 78); 113 | 0.27 |
Girls | 14.0 (5, 64); 435 | 13.00 (6, 64); 234 | 0.26 |
Serum leptin (ng/ml) | |||
Boys | 1.22 (0.40, 13.11); 288 | 1.2 (0.40, 16.04); 120 | 0.99 |
Girls | 13.11 (2.4, 54.57); 265 | 13.11 (2.76, 54.57); 239 | 0.7 |
Maternal asthma during pregnancy | 0.41 | ||
Yes | 137 (10.51) | 44 (12.02) | |
No | 1167 (89.49) | 322 (87.98) | |
Paternal asthma | 0.23 | ||
Yes | 128 (9.88) | 43 (11.88) | |
No | 1168 (90.12) | 319 (88.12) | |
Atopy Status | |||
Boys | 194 (47.7) | 50 (40.6) | 0.17 |
Girls | 159 (35.65) | 76 (31.4) | 0.26 |
Maternal smoking status | 0.23 | ||
Yes | 305 (23.34) | 75 (20.83) | |
No | 1002 (76.66) | 293 (79.62) | |
Current smoking status | 0.29 | ||
Yes | 368 (28.79) | 95 (25.96) | |
No | 910 (71.21) | 271 (74.04) | |
Sex | <0.0001 | ||
Male | 653 (49.73) | 125 (33.78) | |
Female | 660 (50.3) | 245 (66.22) |